The colder months are traditionally the harbinger of winter illnesses. Like the flu, for example. But there's one particular ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Get the latest insights from Moderna's Q3 2025 earnings call: revenue guidance updates, cost reduction highlights, and pipeline progress.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below.

Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...

The UK Health Security Agency (UKHSA) reported on Thursday (November 6) that flu season in England has begun "unusually early ...

Latest cruise ship outbreaks, from norovirus to flu cases. Stay updated on health incidents affecting passengers and cruise itineraries.

Susan Lois Hamilton, chair of the Department of Integrated Physiology, received her Ph.D. in biophysics from the University ...